Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study

This was a multicenter, retrospective, and non-interventional study using secondary data captured in the Electronic Health Records (EHRs). The extraction of the data captured in the EHRs was performed with EHRead® by SAVANA, an innovating data-driven system based on Natural Language Processing (NLP) and big data analytics. Data was extracted and analyzed at Index Date, Follow Up, or as specified for each variable.

Inclusion Criteria:Aged ≥ 18 years.Diagnosed with axSpA or PsA.Had received or are receiving bDMARD, independently of the line of treatment, from January 2018 to data collection.Had at least 3 months follow up from first bDMARD administration.Patients with EHRs.Exclusion Criteria:• Receiving bDMARD within a clinical trial from January 2018 to data collection.